The SPAC in an amended S-4 said shareholders will be asked to approve the issuance of 100 million shares to XL stockholders in the proposed merger. A voted is expected by year’s end. Read more.
Related Posts
Gobi Acquisition Asks Shareholders to Approve Liquidation a Year Early
The goal, the SPAC said in the filing, is to enable shareholders to redeem their investments without waiting another 12 months to do so while earning minimal interest.
Avista Public Acquisition II Files S-4 on $850M OmniAb Deal with Ligand
The combination of OmniAb and AHPA is structured to guarantee a minimum of $130 million in gross cash.
Spartacus Acquisition Files Prelim Proxy on $1.2B NextNav Deal
The deal is expected to provide approximately $408 million in gross proceeds, including a $205 million fully committed PIPE.
LifeSci II Amends Prospectus on $75M IPO
The SPAC is targeting companies in the biopharma, medical technology, digital health, and healthcare services sectors.